- #1,482 Hari Chand Aggarwal & family ₹1,400 Cr

About Insecticides (India) Limited
Data last updated:
Insecticides (India) Limited is a public limited company based in Delhi, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 18 December 1996 and has been in existence for over 30 years.
Its director Hari Chand Aggarwal and family are #1,482 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L65991DL1996PLC083909. Its GSTIN is 07AAACI3076P2Z6 (Delhi). The company holds 31 GST registrations, of which 24 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 532851 and NSE: INSECTICID.
The company has an authorised share capital of ₹35 Cr and a paid-up capital of ₹29.1 Cr. It was formerly known as Insecticides (India) Private Limited. It is led by directors including Rajesh Kumar Aggarwal (Managing Director) and Hari Chand Aggarwal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 12 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 401 – 402, Lusa Tower Azadpur Commercial Complex North West Delhi Delhi – 110033, Delhi, India – 110033.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹2,140.01 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹138.55 Cr (net margin 6.5%) and EBITDA of ₹227.05 Cr (EBITDA margin 10.6%). The net worth stands at ₹1,220.41 Cr (up 12.5% YoY). Total assets are valued at ₹1,380.52 Cr (up 15.5% YoY).
The company has about 1,626 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.
The company is associated with 1 brand: Insecticides. As per MCA filings, the company has open charges of ₹709.14 Cr and satisfied charges of ₹1,009.27 Cr on record. Court records list 342 cases involving the company, including 84 filed by the company and 258 filed against it; 61 cases are pending. The company has 58 deals on record (55 market trades, 1 qip, 1 buyback); the latest was in May 2022. Its 10 peer companies in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Adama India Private Limited with revenue of ₹2,509.85 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 404 overdue payments to 99 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website insecticidesindia.com.
Company details
CIN history
Insecticides (India) has one previous CIN (Corporate Identification Number): U65991DL1996PLC083909. The current CIN is L65991DL1996PLC083909, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L65991DL1996PLC083909 | Current |
| U65991DL1996PLC083909 | Previous |
Recognitions & Rankings of Insecticides (India)
Contact details
Insecticides (India) Limited's registered office is in Delhi, Delhi. Its website is insecticidesindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered Address401 – 402, Lusa Tower Azadpur Commercial Complex North West Delhi Delhi – 110033, Delhi, India – 110033
- IndustryAgriculture, Crop Protection
To see the full contact details of Insecticides (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Insecticides (India) operates one associated brand: Insecticides. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Crop protection agrochemicals are manufactured for crops and household applications. | insecticidesindia.com |
Business activity
The main business activity of Insecticides (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Insecticides (India) Limited, buy the company report.
Financials of Insecticides (India) Limited
FY 2025-26 filings availableInsecticides (India) Limited reported revenue of ₹2,140.01 Cr (up 7% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,140 | 2,000 | 1,966 | 1,801 | 1,504 | 1,420 | 1,363 |
| Revenue growth | +7.0% | +1.7% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| EBITDA | 227 | 221 | 162 | 122 | 170 | 143 | 156 |
| EBITDA margin | +10.6% | +11.1% | +8.3% | +6.8% | +11.3% | +10.0% | +11.4% |
| Profit before tax | 187 | 193 | 132 | 83.84 | 141 | 120 | 111 |
| Net profit | 139 | 142 | 101 | 63.27 | 108 | 101 | 87.22 |
| Net profit margin | +6.5% | +7.1% | +5.1% | +3.5% | +7.2% | +7.1% | +6.4% |
| EPS (₹) | 47.91 | 48.81 | 34.49 | 21.36 | 54.44 | 45.43 | 42.05 |
| Balance sheet | |||||||
| Total assets | 1,381 | 1,195 | 1,101 | 1,083 | 925 | 924 | 924 |
| Net worth | 1,220 | 1,085 | 1,012 | 918 | 870 | 820 | 732 |
| Total debt | 157 | 105 | 87.31 | 163 | 53.95 | 100 | 191 |
| Cash & bank | 87.39 | 57.11 | 61.44 | 19.69 | 36.14 | 83.29 | 74.16 |
| Net working capital | 832 | 717 | 641 | 631 | 544 | 597 | 626 |
| Cash flow | |||||||
| Cash from operations | 100 | 93.46 | 187 | (10.63) | 135 | 155 | 242 |
| Cash from investing | (86.47) | (37.72) | (46.47) | (86.40) | 9.31 | (113) | (24.09) |
| Cash from financing | 17.53 | (61.09) | (98.06) | 79.68 | (115) | (104) | (159) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 612 | 426 | 385 | 638 | 691 | 359 | 358 | 627 |
| Revenue growth (YoY) | -11.5% | +18.8% | +7.6% | +1.7% | +5.2% | - | - | - |
| Other income | 5.61 | 4.73 | 1.01 | 2.86 | 3.90 | 2.86 | 0.38 | 1.69 |
| EBITDA | 67.61 | 25.10 | 27.39 | 89.48 | 84.58 | 28.47 | 30.89 | 89.56 |
| EBITDA margin | +11.1% | +5.9% | +7.1% | +14.0% | +12.2% | +7.9% | +8.6% | +14.3% |
| Depreciation | 9.71 | 9.44 | 9.41 | 9.33 | 7.31 | 7.17 | 7.58 | 7.25 |
| Interest | 4.69 | 4.32 | 4.68 | 4.16 | 3.72 | 2.14 | 1.41 | 1.69 |
| Profit before tax | 58.82 | 16.07 | 14.31 | 78.85 | 77.45 | 22.02 | 22.28 | 82.31 |
| Tax | 14.95 | 4.35 | 3.81 | 19.75 | 19.35 | 8.13 | 4.92 | 20.83 |
| Net profit | 43.87 | 11.72 | 10.50 | 59.10 | 58.10 | 13.89 | 17.36 | 61.48 |
| EPS (₹) | 15.08 | 4.02 | 3.60 | 20.31 | 19.97 | 4.77 | 5.96 | 20.78 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,144 | 2,002 | 1,966 | 1,801 | 1,504 | 1,420 | 1,363 |
| Revenue growth | +7.1% | +1.8% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| EBITDA | 222 | 219 | 163 | 122 | 170 | 143 | 156 |
| EBITDA margin | +10.3% | +10.9% | +8.3% | +6.8% | +11.3% | +10.0% | +11.4% |
| Profit before tax | 182 | 190 | 133 | 83.60 | 141 | 119 | 110 |
| Net profit | 135 | 140 | 101 | 63.03 | 108 | 101 | 86.35 |
| Net profit margin | +6.3% | +7.0% | +5.2% | +3.5% | +7.2% | +7.1% | +6.3% |
| EPS (₹) | 46.68 | 48.03 | 34.67 | 21.28 | 54.24 | 45.21 | 41.63 |
| Balance sheet | |||||||
| Total assets | 1,368 | 1,191 | 1,101 | 1,080 | 923 | 922 | 922 |
| Net worth | 1,214 | 1,082 | 1,011 | 916 | 867 | 818 | 730 |
| Total debt | 151 | 104 | 87.31 | 163 | 53.95 | 100 | 191 |
| Cash & bank | 87.29 | 56.56 | 61.21 | 19.45 | 36.14 | 83.29 | 74.16 |
| Net working capital | 825 | 720 | 648 | 631 | 544 | 597 | 626 |
| Cash flow | |||||||
| Cash from operations | 109 | 94.62 | 185 | (10.62) | 135 | 155 | 242 |
| Cash from investing | (90.17) | (38.71) | (43.83) | (86.71) | 9.31 | (113) | (24.09) |
| Cash from financing | 13.19 | (61.58) | (98.05) | 79.73 | (115) | (104) | (159) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 616 | 428 | 384 | 641 | 691 | 359 | 359 | 627 |
| Revenue growth (YoY) | -10.8% | +19.2% | +6.8% | +2.2% | +5.3% | - | - | - |
| Other income | 4.62 | 4.80 | 0.89 | 2.67 | 3.75 | 2.94 | 0.21 | 1.54 |
| Total expenses | 551 | 401 | 358 | 556 | 607 | 331 | 331 | 537 |
| EBITDA | 65.88 | 27.41 | 25.29 | 84.87 | 84.03 | 28.47 | 28.68 | 89.85 |
| EBITDA margin | +10.7% | +6.4% | +6.6% | +13.2% | +12.2% | +7.9% | +8.0% | +14.3% |
| Depreciation | 9.59 | 9.32 | 9.34 | 9.27 | 7.28 | 7.14 | 7.55 | 7.23 |
| Interest | 4.65 | 4.18 | 4.61 | 4.08 | 3.65 | 2.02 | 1.40 | 1.68 |
| Profit before tax | 56.26 | 18.71 | 12.23 | 74.19 | 76.85 | 22.25 | 19.94 | 82.48 |
| Tax | 14.43 | 4.34 | 3.39 | 18.88 | 19.54 | 8.22 | 4.94 | 20.88 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 612 | 426 | 385 | 638 | 691 | 359 | 358 | 627 |
| Revenue growth (YoY) | -11.5% | +18.8% | +7.6% | +1.7% | +5.2% | - | - | - |
| Other income | 5.61 | 4.73 | 1.01 | 2.86 | 3.90 | 2.86 | 0.38 | 1.69 |
| EBITDA | 67.61 | 25.10 | 27.39 | 89.48 | 84.58 | 28.47 | 30.89 | 89.56 |
| EBITDA margin | +11.1% | +5.9% | +7.1% | +14.0% | +12.2% | +7.9% | +8.6% | +14.3% |
| Depreciation | 9.71 | 9.44 | 9.41 | 9.33 | 7.31 | 7.17 | 7.58 | 7.25 |
| Interest | 4.69 | 4.32 | 4.68 | 4.16 | 3.72 | 2.14 | 1.41 | 1.69 |
| Profit before tax | 58.82 | 16.07 | 14.31 | 78.85 | 77.45 | 22.02 | 22.28 | 82.31 |
| Tax | 14.95 | 4.35 | 3.81 | 19.75 | 19.35 | 8.13 | 4.92 | 20.83 |
| Net profit | 43.87 | 11.72 | 10.50 | 59.10 | 58.10 | 13.89 | 17.36 | 61.48 |
| EPS (₹) | 15.08 | 4.02 | 3.60 | 20.31 | 19.97 | 4.77 | 5.96 | 20.78 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,140 | 2,000 | 1,966 | 1,801 | 1,504 | 1,420 | 1,363 |
| Revenue growth | +7.0% | +1.7% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| Other income | 12.01 | 7.57 | 9.71 | 1.50 | 4.68 | 8.20 | 3.44 |
| Total expenses | 1,913 | 1,779 | 1,804 | 1,679 | 1,334 | 1,278 | 1,207 |
| Employee cost | 164 | 139 | 117 | 98.38 | 86.65 | 76.51 | 74.74 |
| EBITDA | 227 | 221 | 162 | 122 | 170 | 143 | 156 |
| EBITDA margin | +10.6% | +11.1% | +8.3% | +6.8% | +11.3% | +10.0% | +11.4% |
| Depreciation | 35.50 | 29.15 | 29.25 | 26.10 | 26.35 | 24.67 | 24.07 |
| Interest | 16.88 | 6.86 | 10.89 | 13.45 | 6.63 | 6.65 | 23.89 |
| Profit before tax | 187 | 193 | 132 | 83.84 | 141 | 120 | 111 |
| Tax | 47.27 | 50.75 | 29.81 | 20.62 | 33.94 | 25.60 | 24.42 |
| Net profit | 139 | 142 | 101 | 63.27 | 108 | 101 | 87.22 |
| Net profit margin | +6.5% | +7.1% | +5.1% | +3.5% | +7.2% | +7.1% | +6.4% |
| EPS (₹) | 47.91 | 48.81 | 34.49 | 21.36 | 54.44 | 45.43 | 42.05 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 29.10 | 29.10 | 29.60 | 29.60 | 19.73 | 20.67 | 20.67 |
| Reserves & surplus | 1,191 | 1,056 | 982 | 889 | 850 | 800 | 711 |
| Shareholders' funds (net worth) | 1,220 | 1,085 | 1,012 | 918 | 870 | 820 | 732 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 144 | 99.62 | 83.20 | 159 | 49.39 | 96.27 | 187 |
| Unsecured loans | 12.76 | 5.04 | 4.11 | 3.63 | 4.56 | 4.17 | 3.69 |
| Total debt | 157 | 105 | 87.31 | 163 | 53.95 | 100 | 191 |
| Total liabilities | 1,381 | 1,195 | 1,101 | 1,083 | 925 | 924 | 924 |
| Assets | |||||||
| Gross block | 588 | 471 | 451 | 403 | 370 | 337 | 314 |
| Net block | 370 | 282 | 286 | 263 | 253 | 239 | 239 |
| Capital work in progress | 130 | 161 | 142 | 123 | 90.98 | 58.65 | 38.96 |
| Investments | 28.58 | 29.32 | 23.07 | 16.93 | 15.55 | 13.55 | 11.89 |
| Inventories | 780 | 886 | 807 | 862 | 630 | 661 | 519 |
| Sundry debtors | 487 | 385 | 297 | 296 | 289 | 255 | 320 |
| Cash & bank balances | 87.39 | 57.11 | 61.44 | 19.69 | 36.14 | 83.29 | 74.16 |
| Loans & advances | 88.76 | 86.83 | 83.39 | 54.55 | 47.47 | 87.33 | 65.12 |
| Total current assets | 1,443 | 1,416 | 1,249 | 1,232 | 1,003 | 1,086 | 978 |
| Total current liabilities | 611 | 699 | 608 | 601 | 458 | 489 | 352 |
| Net working capital | 832 | 717 | 641 | 631 | 544 | 597 | 626 |
| Total assets | 1,381 | 1,195 | 1,101 | 1,083 | 925 | 924 | 924 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 55.93 | 61.28 | 18.83 | 35.98 | 6.46 | 67.73 | 8.94 |
| Net cash from operating activities | 100 | 93.46 | 187 | (10.63) | 135 | 155 | 242 |
| Net cash from investing activities | (86.47) | (37.72) | (46.47) | (86.40) | 9.31 | (113) | (24.09) |
| Net cash from financing activities | 17.53 | (61.09) | (98.06) | 79.68 | (115) | (104) | (159) |
| Net change in cash | 31.30 | (5.36) | 42.45 | (17.35) | 29.52 | (61.27) | 58.79 |
| Closing cash | 87.39 | 57.11 | 61.44 | 19.69 | 36.14 | 83.29 | 74.16 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.0% | +1.7% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| EBITDA growth | +2.6% | +36.3% | +33.2% | -28.2% | +19.0% | -8.5% | - |
| PBT growth | -3.2% | +46.2% | +57.3% | -40.7% | +18.3% | +7.3% | -27.4% |
| Net income growth | -2.2% | +40.7% | +59.2% | -41.6% | +6.9% | +16.3% | - |
| Revenue CAGR (3Y) | +5.9% | +10.0% | +11.5% | +9.7% | +8.0% | +6.2% | +11.1% |
| EBITDA CAGR (3Y) | +23.0% | +9.3% | +4.4% | -7.9% | -3.2% | -1.2% | +11.9% |
| Profitability & leverage | |||||||
| Net income margin | +6.5% | +7.1% | +5.2% | +3.5% | +7.1% | +6.6% | +6.4% |
| Return on capital employed | +15.8% | +17.4% | +13.1% | +9.7% | +16.0% | +13.7% | +14.3% |
| Return on net worth | +12.1% | +13.6% | +10.6% | +7.1% | +12.7% | +12.1% | +12.5% |
| Debt / equity | 0.11 | 0.09 | 0.13 | 0.12 | 0.09 | 0.19 | 0.36 |
| Long-term debt / equity | 0.03 | 0.04 | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest cover | 8.81 | 3.57 | 8.18 | 14.04 | 4.63 | 5.64 | 18.13 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 4.04 | 4.34 | 4.61 | 4.66 | 4.26 | 4.37 | 4.50 |
| Inventory turnover | 2.57 | 2.36 | 2.36 | 2.41 | 2.33 | 2.41 | 2.23 |
| Debtors turnover | 4.91 | 5.87 | 6.63 | 6.16 | 5.53 | 4.95 | 4.83 |
| EPS (₹) | 47.91 | 48.81 | 34.49 | 21.36 | 54.44 | 45.43 | 42.05 |
| Dividend per share (₹) | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 2.00 | 4.00 |
| Book value per share (₹) | 419.42 | 372.74 | 341.82 | 310.26 | 440.71 | 396.93 | 354.04 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 616 | 428 | 384 | 641 | 691 | 359 | 359 | 627 |
| Revenue growth (YoY) | -10.8% | +19.2% | +6.8% | +2.2% | +5.3% | - | - | - |
| Other income | 4.62 | 4.80 | 0.89 | 2.67 | 3.75 | 2.94 | 0.21 | 1.54 |
| Total expenses | 551 | 401 | 358 | 556 | 607 | 331 | 331 | 537 |
| EBITDA | 65.88 | 27.41 | 25.29 | 84.87 | 84.03 | 28.47 | 28.68 | 89.85 |
| EBITDA margin | +10.7% | +6.4% | +6.6% | +13.2% | +12.2% | +7.9% | +8.0% | +14.3% |
| Depreciation | 9.59 | 9.32 | 9.34 | 9.27 | 7.28 | 7.14 | 7.55 | 7.23 |
| Interest | 4.65 | 4.18 | 4.61 | 4.08 | 3.65 | 2.02 | 1.40 | 1.68 |
| Profit before tax | 56.26 | 18.71 | 12.23 | 74.19 | 76.85 | 22.25 | 19.94 | 82.48 |
| Tax | 14.43 | 4.34 | 3.39 | 18.88 | 19.54 | 8.22 | 4.94 | 20.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,144 | 2,002 | 1,966 | 1,801 | 1,504 | 1,420 | 1,363 |
| Revenue growth | +7.1% | +1.8% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| Other income | 12.11 | 7.23 | 9.51 | 1.26 | 4.27 | 7.73 | 2.57 |
| Total expenses | 1,923 | 1,783 | 1,803 | 1,679 | 1,334 | 1,278 | 1,207 |
| Employee cost | 160 | 137 | 117 | 98.38 | 86.65 | 76.51 | 74.74 |
| EBITDA | 222 | 219 | 163 | 122 | 170 | 143 | 156 |
| EBITDA margin | +10.3% | +10.9% | +8.3% | +6.8% | +11.3% | +10.0% | +11.4% |
| Depreciation | 35.22 | 29.05 | 29.25 | 26.10 | 26.35 | 24.67 | 24.07 |
| Interest | 16.51 | 6.72 | 10.88 | 13.45 | 6.63 | 6.65 | 23.89 |
| Profit before tax | 182 | 190 | 133 | 83.60 | 141 | 119 | 110 |
| Tax | 46.16 | 50.52 | 29.95 | 20.62 | 33.94 | 25.60 | 24.42 |
| Net profit | 135 | 140 | 101 | 63.03 | 108 | 101 | 86.35 |
| Net profit margin | +6.3% | +7.0% | +5.2% | +3.5% | +7.2% | +7.1% | +6.3% |
| EPS (₹) | 46.68 | 48.03 | 34.67 | 21.28 | 54.24 | 45.21 | 41.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 29.10 | 29.10 | 29.60 | 29.60 | 19.73 | 20.67 | 20.67 |
| Reserves & surplus | 1,185 | 1,053 | 982 | 886 | 847 | 798 | 710 |
| Shareholders' funds (net worth) | 1,214 | 1,082 | 1,011 | 916 | 867 | 818 | 730 |
| Secured loans | 139 | 98.99 | 83.20 | 159 | 49.39 | 96.27 | 187 |
| Unsecured loans | 12.53 | 5.04 | 4.11 | 3.63 | 4.56 | 4.17 | 3.69 |
| Total debt | 151 | 104 | 87.31 | 163 | 53.95 | 100 | 191 |
| Total liabilities | 1,368 | 1,191 | 1,101 | 1,080 | 923 | 922 | 922 |
| Assets | |||||||
| Gross block | 583 | 468 | 448 | 402 | 370 | 337 | 314 |
| Net block | 364 | 278 | 283 | 262 | 253 | 239 | 239 |
| Capital work in progress | 130 | 161 | 141 | 123 | 90.98 | 58.65 | 38.96 |
| Investments | 30.49 | 26.46 | 18.59 | 15.45 | 13.15 | 11.57 | 10.40 |
| Inventories | 768 | 883 | 806 | 862 | 630 | 661 | 519 |
| Sundry debtors | 490 | 386 | 297 | 296 | 289 | 255 | 320 |
| Cash & bank balances | 87.29 | 56.56 | 61.21 | 19.45 | 36.14 | 83.29 | 74.16 |
| Loans & advances | 87.24 | 86.77 | 82.86 | 54.54 | 47.47 | 87.33 | 65.12 |
| Total current assets | 1,432 | 1,412 | 1,247 | 1,232 | 1,003 | 1,086 | 978 |
| Total current liabilities | 608 | 691 | 599 | 601 | 458 | 489 | 352 |
| Net working capital | 825 | 720 | 648 | 631 | 544 | 597 | 626 |
| Total assets | 1,368 | 1,191 | 1,101 | 1,080 | 923 | 922 | 922 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 55.38 | 61.05 | 18.38 | 35.98 | 6.46 | 67.73 | 8.94 |
| Net cash from operating activities | 109 | 94.62 | 185 | (10.62) | 135 | 155 | 242 |
| Net cash from investing activities | (90.17) | (38.71) | (43.83) | (86.71) | 9.31 | (113) | (24.09) |
| Net cash from financing activities | 13.19 | (61.58) | (98.05) | 79.73 | (115) | (104) | (159) |
| Net change in cash | 31.75 | (5.67) | 42.67 | (17.60) | 29.52 | (61.27) | 58.79 |
| Closing cash | 87.29 | 56.56 | 61.21 | 19.45 | 36.14 | 83.29 | 74.16 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.1% | +1.8% | +9.2% | +19.8% | +5.9% | +4.2% | - |
| EBITDA growth | +1.3% | +34.1% | +33.9% | -28.2% | +19.0% | -8.5% | - |
| PBT growth | -4.4% | +43.5% | +58.6% | -40.7% | +18.4% | +7.8% | -27.8% |
| Net income growth | -3.1% | +37.7% | +60.8% | -41.6% | +7.0% | +16.9% | - |
| Revenue CAGR (3Y) | +6.0% | +10.0% | +11.5% | +9.7% | +8.0% | +6.2% | +11.1% |
| EBITDA CAGR (3Y) | +22.1% | +8.9% | +4.6% | -7.9% | -3.2% | -1.2% | +11.9% |
| Profitability & leverage | |||||||
| Net income margin | +6.3% | +7.0% | +5.2% | +3.5% | +7.1% | +6.6% | +6.3% |
| Return on capital employed | +15.5% | +17.2% | +13.2% | +9.7% | +16.0% | +13.6% | +14.2% |
| Return on net worth | +11.8% | +13.4% | +10.7% | +7.1% | +12.7% | +12.1% | +12.4% |
| Debt / equity | 0.11 | 0.09 | 0.13 | 0.12 | 0.09 | 0.19 | 0.36 |
| Long-term debt / equity | 0.03 | 0.04 | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest cover | 8.86 | 3.54 | 8.12 | 14.04 | 4.63 | 5.64 | 18.13 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 4.08 | 4.37 | 4.63 | 4.67 | 4.26 | 4.37 | 4.50 |
| Inventory turnover | 2.60 | 2.37 | 2.36 | 2.41 | 2.33 | 2.41 | 2.23 |
| Debtors turnover | 4.90 | 5.87 | 6.63 | 6.16 | 5.53 | 4.95 | 4.83 |
| EPS (₹) | 46.68 | 48.03 | 34.67 | 21.28 | 54.24 | 45.21 | 41.63 |
| Dividend per share (₹) | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 2.00 | 4.00 |
| Book value per share (₹) | 417.21 | 371.78 | 341.61 | 309.38 | 439.50 | 395.98 | 353.32 |
To see the full year-wise statements and ratios of Insecticides (India) Limited, buy the company report.
Board of directors of Insecticides (India) Limited
Insecticides (India) has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Chand Aggarwal | Whole-Time Director | 12 Oct 2001 | 25 Years 0 Months | Current |
| Rajesh Kumar Aggarwal Also directs: Iil Biologicals Limited, Crop Care Federation of India, Oat & Iil India Laboratories Private Limited and 2 more | Managing Director | 18 Dec 1996 | 29 Years 10 Months | Current |
| Praveen Gupta Also directs: H A P G & Associates LLP, Prakash Pipes Limited | Director | 15 Feb 2020 | 6 Years 8 Months | Current |
| Anil Kumar Goyal Also directs: Iil Biologicals Limited, Kaeros Research Limited | Whole-Time Director | 20 Aug 2022 | 4 Years 2 Months | Current |
| Anil Kumar Bhatia | Director | 20 Aug 2022 | 4 Years 2 Months | Current |
| Shyam Lal Bansal Also directs: Sammaan Asset Management Limited | Director | 05 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Insecticides (India) Limited is compared with the 10 companies closest to it by revenue in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adama India Private Limited | ₹2,509.85 Cr (FY 2025) | -4.0% | Medchal Malkajgiri, Telangana, India | |||
| Bayer Vapi Private Limited | ₹2,200.3 Cr (FY 2025) | -10.0% | Vapi, Gujarat, India | |||
| Insecticides (India) Limitedthis company | ₹2,140.01 Cr (FY 2026) | ₹138.55 Cr | 6.5% | 7.0% | 1,626 | Delhi, India |
| Meghmani Organics Limited | ₹2,123.62 Cr (FY 2025) | 32.0% | Ahmedabad, Gujarat, India | |||
| Willowood Chemicals Limited | ₹2,111.28 Cr (FY 2025) | 16.0% | Kolkata, West Bengal, India | |||
| Dhanuka Agritech Limited | ₹2,071.26 Cr (FY 2025) | 15.0% | Gurgaon, Haryana, India | |||
| Safex Chemicals ( India) Limited | ₹1,605.82 Cr (FY 2025) | 13.0% | Delhi, India | |||
| Krishi Rasayan Exports Pvt.Ltd. | ₹1,596.3 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Heranba Industries Limited | ₹1,417.31 Cr (FY 2025) | 12.0% | Vapi, Gujarat, India | |||
| GSP Crop Science Limited | ₹1,301.06 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Nacl Industries Limited | ₹1,242.56 Cr (FY 2025) | -30.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Insecticides (India) Limited, buy the company report.
Auditor
Insecticides (India) Limited is audited by S S Kothari Mehta & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S S Kothari Mehta & Company | FY 2023 | 000756N 000756N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 72.30%, foreign institutional investors hold 4.40%, domestic institutional investors hold 9.30% and retail and other public shareholders hold 14.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 72.30% | 72.30% | 72.30% | 72.30% |
| Public | 27.70% | 27.70% | 27.70% | 27.70% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2026 | 101379056 | Hdfc Bank Limited | ₹7.6 Lakh | Open | |
| 07 Aug 2026 | 101370878 | Hdfc Bank Limited | ₹6.6 Lakh | Open | |
| 07 Aug 2026 | 101370880 | Hdfc Bank Limited | ₹7.82 Lakh | Open | |
| 07 Aug 2026 | 101370892 | Hdfc Bank Limited | ₹6.43 Lakh | Open | |
| 07 Aug 2026 | 101370886 | Hdfc Bank Limited | ₹6.47 Lakh | Open |
To see the full charge records of Insecticides (India) Limited, buy the company report.
Total charge records: 297 View all charges
Deals & funding
Insecticides (India) Limited has 58 deals on record (55 market trades, 1 qip, 1 buyback); the latest was in May 2022.
Deals on record (5 of 58)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Market trade | ₹8.42 Cr | Seller: O J Financial Services Limited |
| Jun 2021 | Market trade | ₹9.11 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| May 2021 | Market trade | ₹16.39 Cr | Buyer: Insecticides (India) Limited , an individual Seller: an individual |
| Nov 2013 | Market trade | ₹14.49 Cr | Buyer: Vinod Infotech Pvt Ltd , Padmashree Inc, an individual Seller: Ruane Cunniff And Goldfard Inc A/C Acacia Institutional Par, Padmashree Inc, Vinod Infotech Pvt Ltd |
| Jun 2012 | Market trade | ₹2.76 Cr | Buyer: Multiplex Capital Limited Seller: Multiplex Capital Limited |
To see the full deal history of Insecticides (India) Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Insecticides (India) Limited has 342 court cases on record: 84 filed by Insecticides (India), 258 filed against it. 61 cases are pending and 281 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 171 | 137 | 13 |
| District courts | 158 | 112 | 47 |
| Supreme Court | 10 | 9 | 1 |
| NCLAT | 2 | 0 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 342)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Chairperson Court | Tribunal matter | Filed by the company against Gupta Biotech Private Limited | Disposed |
| NCLT, New Delhi Bench Court-III | Insolvency matter | Filed by the company against Gupta Biotech Private Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Anu Products Limited | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
| District court, Jabalpur, Madhya Pradesh | Court case (MACC) | Filed against the company by an individual | Pending |
To see the full case history of Insecticides (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Insecticides (India) Limited was last rated by Crisil on 19 Mar 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 19 Mar 2020 |
To see the full credit ratings and regulatory alerts of Insecticides (India) Limited, buy the company report.
MSME payment delays
Insecticides (India) Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 404 overdue payments to 99 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 99)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ekopak India Private Limited | |||
| an individual supplier | |||
| Saksham Containers Private Limited | |||
| an individual supplier | |||
| Phytochem Remedies (India) Limited |
To see the full MSME payment records of Insecticides (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Insecticides (India) has 1 subsidiary company and 1 joint venture. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Iil Biologicals Limited | U01100DL2022PLC401834 |
To see the full group structure of Insecticides (India) Limited, buy the company report.
Employees & EPFO
Insecticides (India) Limited has a workforce of 1,626 employees on its EPFO records as of Sep 16, 2024, across 4 active EPFO establishments.
GST
Insecticides (India) has 31 GST registrations: 24 active and 7 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACI3076P2Z6 | Delhi | Active | 09 Jul 2017 |
| 07AAACI3076P3Z5 | Delhi | Active | 01 Jul 2024 |
| 03AAACI3076P1ZF | Punjab | Active | 01 Jul 2017 |
| 05AAACI3076P1ZB | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Insecticides (India) Limited, buy the company report.
Recent activity
Insecticides (India) Limited has 19 board changes on record since 1996: 8 appointments and 11 cessations. The latest: Sanskar Aggarwal was appointed as Whole-Time Director on 28 May 2026.
489 earlier events are in the company report.
News
Frequently asked questions
Insecticides (India) is an active public limited company based in Delhi, India. The company works in crop protection, within the agriculture industry. It was incorporated on 18 December 1996 (30+ years old) and is registered under CIN L65991DL1996PLC083909. Listed on BSE: 532851 and NSE: INSECTICID.
Insecticides (India) reported revenue of ₹2,140.01 Cr for FY 2025-26 (up 7% YoY) based on consolidated financials.
Insecticides (India) has 8 current directors:
- Rajesh Kumar Aggarwal - Managing Director
- Hari Chand Aggarwal - Whole-Time Director
- Anil Kumar Goyal - Whole-Time Director
- Sanskar Aggarwal - Whole-Time Director
- Praveen Gupta - Director
- Anil Kumar Bhatia - Director
- Shyam Lal Bansal - Director
- Supratim Bandyopadhyay - Director
The latest financial statements of Insecticides (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 12 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Insecticides (India) is 07AAACI3076P2Z6, registered in Delhi. The company has 31 GST registrations in all, of which 24 are active and 7 are cancelled or inactive. Other active GSTINs include 07AAACI3076P3Z5 (Delhi), 03AAACI3076P1ZF (Punjab), 05AAACI3076P1ZB (Uttarakhand).
The CIN (Corporate Identification Number) of Insecticides (India) is L65991DL1996PLC083909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Insecticides (India) is a listed company as per MCA records. Its shares are listed on both BSE (code: 532851) and NSE (symbol: INSECTICID).
Insecticides (India) has 342 court cases on record: 84 filed by the company and 258 filed against it. 61 are pending. Most are in the high courts.
Insecticides (India) was incorporated on 18 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Insecticides (India) has 58 deals on record (55 market trades, 1 qip, 1 buyback); the latest was in May 2022.
The peers of Insecticides (India) by revenue are Adama India Private Limited, Bayer Vapi Private Limited, Meghmani Organics Limited, Willowood Chemicals Limited, Dhanuka Agritech Limited and 5 more, all in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanskar Aggarwal was appointed as Whole-Time Director on 28 May 2026. Shyam Lal Bansal was appointed as Director on 05 Feb 2024. Supratim Bandyopadhyay was appointed as Director on 05 Feb 2024. Insecticides (India) has 19 board changes on record in total.